Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress

Area of Science:

• Hepatology
• Pharmacology
• Toxicology

Background:

• Alcoholic liver disease (ALD) is a major health concern.
• Oxidative stress, inflammation, and apoptosis are key pathological mechanisms in ALD.
• Resveratrol, a natural polyphenol, has shown potential therapeutic benefits.

Purpose of the Study:

• To investigate the hepatoprotective effects of resveratrol in a rat model of alcoholic liver disease.
• To elucidate the molecular mechanisms underlying resveratrol's action in ALD.

Main Methods:

• Alcohol was administered to female rats, gradually increasing concentration.
• Liver enzymes, antioxidant enzymes, oxidative stress markers, and caspase 3 activity were measured.
• Hepatic CYP2E1 protein and gene expression of antioxidant and inflammation markers were analyzed using Western blotting and RT-PCR.

Main Results:

• Resveratrol significantly reduced elevated liver enzymes (AST, ALT) and improved antioxidant enzyme activity.
• Resveratrol attenuated alcohol-induced increases in CYP2E1, oxidative stress, and apoptosis (caspase 3 activity).
• Resveratrol modulated the expression of genes involved in oxidative stress and inflammation.

Conclusions:

• Resveratrol alleviates alcoholic liver disease in rats.
• The protective effects are mediated by the regulation of oxidative stress, apoptosis, and inflammation at the transcriptional level.
• Resveratrol is a promising natural therapeutic agent for chronic ALD.